Short answer
Centene Corporation (CNC) filed its Q2 2025 10-Q quarterly report on Jul 25, 2025 for the quarter ended Jun 30, 2025. Quarterly revenue was $42.5B (up 18.1% year over year) with net income of −$253M.
Q2 2025 key financials · XBRL
- Revenue
- $42.5B
- +18.1% YoY · −0.1% QoQ
- Net income
- −$253M
- −122.1% YoY · −119.3% QoQ
- Operating margin
- -1.1%
- Gross margin
- 7.1%
- EPS (diluted)
- −$0.50
- −123.1% YoY · −119.0% QoQ
Source: XBRL data from the Centene Corporation (CNC) Q2 2025 10-Q on SEC EDGAR. USD.
Centene Corporation Q2 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New risk: 2025 Marketplace morbidity higher than expected due to independent actuarial data and increased Medicaid costs in behavioral health and drugs
- Most updated risk: Expiration of COVID-19 Public Health Emergency increased Medicaid member acuity, raising health benefits ratio and delaying adequate rate adjustments
- Regulatory risk: January 1, 2026 OBBBA restrictions on APTCs require full IRS reimbursement for overpayments and prohibit APTCs during income-related Special Enrollment Periods
- Market risk: Increased competitive pressures and broker incentives in Marketplace and Medicare products may reduce enrollment and profitability
- Financial risk: CMS Part D risk-sharing payments expected 12-13 months post plan year close; delays could materially impact cash flows and liquidity
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Centene Corporation quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.